http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2506077-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4473ce9a30b399c1995a93cc8e81075e |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 |
| filingDate | 2013-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4724022d06709b33bf5a41fd2c4891e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4dd04ebc681f6f86bfd1384f8aaf9a9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6914032c09fe89d540d2a0bcd3cd3190 |
| publicationDate | 2014-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2506077-C1 |
| titleOfInvention | Combination for prevention, correction and therapy of pain related to neurodegeneration or associated with somatoform disorders |
| abstract | FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents a combination for the prevention, correction and therapy of pain related to neurodegeneration and/or associated with somatoform disorders, characterised by the fact that it consists of buspirone and doxepin taken in therapeutically effective amounts. n EFFECT: invention provides creating the combination providing the prolonged analgesic effect, including in persistent chronic pains. n 5 cl, 2 ex, 2 tbl |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021235983-A1 |
| priorityDate | 2013-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 100.